<DOC>
	<DOCNO>NCT02242721</DOCNO>
	<brief_summary>Approximately 300 patient enrol study . They follow end ICU stay . Usually clinical routine , patient suspect infection simultaneously renal dysfunction make CVVHDF necessary . After enrolment blood dialysate specimen draw sent analysis specific time point . The analysis result send back study team Charité - Universitätsmedizin Berlin enable optimize antiinfectiva treatment study patient . Data use test calculation tool modify necessary .</brief_summary>
	<brief_title>Drugmonitoring Antiinfective Drugs Patients Receiving Continous Veno-venous Hemodiafiltration ( ABx-CVVHDF )</brief_title>
	<detailed_description>Little data exist whether desire necessary blood level antiinfective drug reach renal replacement therapy . Drug produce company able come forward appropriate dose recommendation patient need renal replacement therapy . To achieve study goal plan : 1 . To measure serum-concentrations antiinfective drug apply patient 2 . To measure concentration antiinfective drug hemofiltration fluid . 3 . To compare actual measure concentration concentration predict known calculation tool . 4 . To modify calculation tool necessary good prediction .</detailed_description>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Male female patient , age ≥ 18 year Patients intensive care unit ( ICU ) , need renal replacement therapy due renal dysfunction treat antiinfective drug Pregnancy lactation period . Participation clinical intervention study Lacking willingness save hand data within study Accommodation institution due official judicial order The informed consent patient subject 's legally acceptable representative can´t obtain time Patient power attorney patient 's provision , he/she refuse participation clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>